By Jamey Keaten — AP, Thursday 9 December 2021
GENEVA (AP) — The World Health Organization (WHO) expressed concerns Thursday that rich countries spooked by the emergence of the Omicron variant could step up the hoarding of COVID-19 vaccines and strain global supplies again, complicating efforts to stamp out the pandemic. The UN health agency, after a meeting of its expert panel on vaccination, reiterated its advice to governments against the widespread use of boosters in their populations so that well-stocked countries can instead send doses to low-income countries that have largely lacked access to them.
“What is going to shut down disease is for everybody who is especially at risk of disease to become vaccinated,” said Dr Kate O’Brien, head of WHO’s department of immunization, vaccines and biologicals. “We seem to be taking our eye off that ball in countries.”
Months of short supplies of COVID-19 vaccines have begun to ease over the last two months, and doses are finally getting to needier countries through donations and the UN-backed COVAX programme. WHO has long decried “vaccine inequity” by which most doses have gone to people in rich countries.
“As we head into whatever the Omicron situation is going to be, there is risk that the global supply is again going to revert to high-income countries hoarding vaccine,” O’Brien said. “It’s not going to work from an epidemiological perspective, and it’s not going to work from a transmission perspective, unless we actually have vaccine going to all countries, because where transmission continues, that’s where the variants are going to come from.”
Many questions remain about the severity, transmissibility and resistance to vaccines of the new Omicron variant, which emerged last month in southern Africa and has shown early signs of spreading faster than the Delta variant. O’Brien urged a “rational, global perspective” about what is “actually going to shut down this pandemic,” adding that “the next days and weeks are really going to determine what direction the world decides it’s going to go in, on Omicron.”